Previous studies also showed stronger associations for frontal, temporal, and parietal tau PET with cognition [11, 50] and temporoparietal [18F]flortaucipir with atrophy [11] compared to CSF p-tau in AD, further supporting the use of especially tau PET to track disease severity. This evidence concerns the gene MAPT and Alzheimer disease.